openPR Logo
Press release

Schistosomiasis Diseases Market to Grow at a CAGR of 4% by 2029 | Industry Trends, Size, Share, Demand, Growth Drivers, and Competitive Landscape

Schistosomiasis Diseases Market to Grow at a CAGR of 4% by 2029 |

The expected CAGR of global schistosomiasis diseases market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 70 million in 2021, and it would grow upto USD 95.80 million by 2029.

Schistosomiasis is also known as bilharzia, a tropical disease caused by a group of parasitic worms called blood flukes belonging to the genus Schistosoma. The disease is transmitted through the consumption of freshwater infected from the larva of parasitic worms. This parasite penetrates into the human skin to reach blood stream and travel to the liver, intestine and other organs. The characteristics sign and symptoms of the abdominal pain, chills and fatigue.

Browse More About This Research Report @
https://www.databridgemarketresearch.com/reports/global-schistosomiasis-diseases-market

Some of the major players operating in the Schistosomiasis Diseases market report are Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Abbvie, Inc (U.S.), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), Bausch Health Companies Inc. (Canada), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Seagen, Inc (U.S.), ONO Pharmaceutical Co., Ltd. (Japan) among others.

Competitive Landscape and Global Schistosomiasis Diseases Market Share Analysis :

The schistosomiasis diseases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to schistosomiasis diseases market.

Browse Trending Reports:

https://dbmr064rs.blogspot.com/2025/03/laser-phosphor-display-lpd-market.html

https://dbmr064rs.blogspot.com/2025/02/antibiotics-in-animal-feed-market.html

https://dbmr064rs.blogspot.com/2025/02/flaxseed-market-overview-trends.html

https://dbmr064rs.blogspot.com/2025/03/digital-identity-solution-market.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Contact Us: -

Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 1177
Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Schistosomiasis Diseases Market to Grow at a CAGR of 4% by 2029 | Industry Trends, Size, Share, Demand, Growth Drivers, and Competitive Landscape here

News-ID: 3940126 • Views:

More Releases from Data Bridge Market Research

Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Schistosomiasis

Drugs for Schistosomiasis Market - key players covered:EIPICO, Chandra Bhagat Ph …
Los Angeles, United State, –The report titled Global Drugs for Schistosomiasis Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Drugs for Schistosomiasis market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of
Schistosomiasis Therapeutics- Pipeline Analysis 2018
Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure. Download the sample report @ https://www.pharmaproff.com/request-sample/1070 School children are more prone to schistosomiasis due to lack of hygiene and certain play habits, such as swimming or fishing in infested water. Symptoms of schistosomiasis are caused by the body’s reaction to the worms' eggs.
Schistosomiasis-Pipeline Review H2 2018
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain. Report Highlights Publisher's Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis-Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by
Schistosomiasis Treatment Market Opportunity Analysis, 2018-2026
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic,
Schistosomiasis - Pipeline Insight and Review, H1 2018
Market Research HUB has recently added a latest Pharmaceutical and Healthcare disease pipeline guide Schistosomiasis - Pipeline Review, H1 2018, provides an overview of the Schistosomiasis (Infectious Disease) pipeline landscape. Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle
Schistosomiasis Pharmaceutical and Healthcare Pipeline Review H1
Summary Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by